🔗 Share this article

This year's prestigious award in Physiology or Medicine has been granted for revolutionary findings that clarify how the body's defense network targets harmful pathogens while protecting the healthy tissues.

Three esteemed researchers—from Japan Prof. Sakaguchi and American experts Mary Brunkow and Dr. Ramsdell—share this accolade.

The research uncovered unique "security guards" within the immune system that remove rogue defense cells that could harming the body.

These findings are now paving the way for innovative therapies for immune disorders and cancer.

These winners will divide a monetary award valued at 11m Swedish kronor.

Decisive Findings

"Their work has been decisive for comprehending how the immune system functions and the reason we don't all develop serious autoimmune diseases," stated the chair of the Nobel Committee.

This team's research explain a fundamental question: How does the immune system defend us from numerous invaders while leaving our healthy cells intact?

Our immune system uses white blood cells that search for indicators of disease, even pathogens and bacteria it has never encountered.

These cells utilize sensors—known as recognition units—that are produced randomly in a vast number of combinations.

That provides the immune system the capacity to fight a wide array of invaders, but the unpredictability of the mechanism inevitably produces white blood cells that may attack the host.

Protectors of the Body

Scientists previously understood that some of these problematic defense cells were destroyed in the thymus—where immune cells develop.

This year's award recognizes the identification of regulatory T-cells—known as the body's "peacekeepers"—which patrol the body to neutralize other immune cells that attack the body's own tissues.

We know that this process fails in autoimmune diseases such as type-1 diabetes, MS, and RA.

A Nobel panel stated, "The findings have laid the foundation for a novel area of investigation and spurred the creation of new therapies, for instance for cancer and autoimmune diseases."

Regarding cancer, T-regs prevent the body from fighting the growth, so research are aimed at lowering their quantity.

In autoimmune diseases, experiments are exploring boosting T-reg cells so the body is no longer under attack. A comparable approach could also be effective in minimizing the chances of transplanted organ failure.

Pioneering Experiments

Professor Sakaguchi, from Osaka University, performed experiments on mice that had their thymus extracted, causing self-attack conditions.

The researcher demonstrated that injecting defense cells from healthy animals could stop the disease—suggesting there was a system for blocking defenders from attacking the body.

Dr. Brunkow, affiliated with the a research center in a US city, and Fred Ramsdell, currently at Sonoma Biotherapeutics in a California city, were investigating an genetic immune disorder in mice and humans that led to the identification of a gene vital for how T-regs function.

"Their groundbreaking work has uncovered how the body's defenses is controlled by regulatory T cells, preventing it from accidentally attacking the healthy cells," commented a leading biological science expert.

"This work is a striking example of how fundamental biological research can have broad implications for public health."